Find out more about Alliance Trust’s performance, with the help of market commentary from our Investment Manager.
Over January, the Trust’s total shareholder return, NAV total return and equity portfolio return were 0.7%, 1.3% and 1.4% respectively, outperforming the MSCI All Country World Index (ACWI) which returned 0.5% over the same period.
Since 1 April 2017*, the Trust’s equity portfolio has outperformed the MSCI ACWI by 3.1% with underlying managers’ stock selection decisions continuing to be the most significant driver of this relative outperformance. Our target allocations remain unchanged, and we have utilised proceeds from the Trust’s sale of shares in Liontrust to top-up those managers who were underweight their target allocations. As a result of the Liontrust sale, a greater proportion of the Trust’s assets are now invested in the equity portfolio.
During January, Aetna has dropped out of the top 20 holdings of the portfolio due to one of the underlying managers reducing their exposure to the stock. This stock has been replaced in the top 20 holdings by Page Group.
* Date Willis Towers Watson assumed responsibility for management of the portfolio
For more market insight, read our view from the Investment Manager.Monthly Factsheet Quarterly Newsletter Sign up for updates
Alliance Trust has been awarded the AIC’s Dividend Hero award and is proud to have increased its dividend every year for over 50 years. This award is made by the Association of Investment Companies to the small number of investment companies who have increased their dividends each year for 20 years or more. For more information and a full list of qualifying companies, you can visit the AIC website.More information